Related posts

Markets fade slightlyMarkets sideways before Fed announcementFlat Friday snaps 9-week streak
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

Cigna Corp. (CI-N) is experiencing a downturn in shares due to market fears of a tie-up deal with Humana, although CI has bowed out. This is seen as positive news, especially given Humana's current issues. The management team is highly regarded for making sound deals, and the company has demonstrated a 13% compound annual growth rate in EPS from 2013-2023. Additionally, they are actively buying back shares and paying dividends to investors. Analysts have set a price target of $397.05 for CI-N.

Consensus
Positive
Valuation
Fair Value
TOP PICK
Cigna Corp.

Shares are down because the market fears they will do a tie-up deal with Humana, but CI bowed out. This is good given Human's problems. Managers are excellent, making good deals. EPS grew 13% compounded annual growth rate from 2013-2023. Are buying back shares and pay a dividend.

(Analysts’ price target is $397.05)
Financial Services
PAST TOP PICK
Cigna Corp.
(A Top Pick Jul 27/22, Up 8%)

Exited, and allocated proceeds to UNH, as it's a better performer, larger scale. He also had concerns over customer concentration. Not expensive at 12x forward earnings plus 1.7% yield.

Financial Services
TOP PICK
Cigna Corp.
Healthcare is a unique performer during times of economic deceleration, providing defense and growth. Stable contract with US Defense Department. Share repurchase. 12x forward earnings, value name. 11% growth rate. Reports August 4. Yield is 1.65%. (Analysts’ price target is $295.36)
Financial Services
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
Cigna Corp.
(A Top Pick Feb 11/21, Up 16.8%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with CI has triggered its $245 stop. We recommend covering the balance of the position at this time. Combined with the previous recommendation to cover 50%, this creates a total investment return over 19%
Financial Services
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
Cigna Corp.
(A Top Pick Feb 11/21, Up 22.5%)Stockchase Research Editor: Michael O'Reilly CI has achieved our objective of $257. To be disciplined we recommend covering 50% of the position and trailing up the stop from $167 to $245. This would all but guarantee a minimum investment return of 19% if triggered.
Financial Services
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Cigna Corp.
Stockchase Research Editor: Michael O'Reilly CI provides healthcare insurance and services in the US and 30 countries worldwide. They have over 170 million customers. It trades at 15x earnings, compared to the peer average of 23x. Its PEG ratio is 0.95 with earnings growth exceeding 27% this year. Earnings are expected to grow over 10% annually for the next five years. It pays a dividend backed by a payout ratio of only 0.3%. We would buy this with a stop-loss at $167, looking to achieve $257 -- upside exceeding 22%. Yield 1.89% (Analysts’ price target is $257.25)
Financial Services
DON'T BUY
Cigna Corp.
There are better opportunities. It is in a tough space. It is probably not a good market in which to hold stocks that face challenges. All countries are putting pressure on drug prices.
Financial Services
TOP PICK
Cigna Corp.
US health insurance under pressure. Very cheap. Will benefit from next Democratic government when it makes Obamacare better. Retirees who are living off medicare, but want to buy extra insurance, will go to a company like Cigna. Best value without taking on drug pricing or pipeline risk. Huge tailwind in US healthcare space. Yield is 0.02%. (Analysts’ price target is $214.83)
Financial Services
WATCH
Cigna Corp.
Merged with Express Scripts. Whole sector is under pressure because of a recent announcement. Important area which helps keep medical expenses low. He's looking at the sector.
Financial Services
PAST TOP PICK
Cigna Corp.

(A Top Pick Sept 20/16. Up 43%.) He continues to like the US healthcare sector. In the US, if over 65 years of age, you spend 3X as much on healthcare as under the age of 65. This company doesn’t have much exposure to the Affordable Care Act and is well positioned to benefit from those trends.

Financial Services
PAST TOP PICK
Cigna Corp.

(Top Pick Aug 17/16, Up 39.68%) A US based health insurance company. The news was that last year Anthem had made an offer for them, but he thought the takeover would not go through. There is a large break fee for the deal not going through. He thinks going forward they will buy back stock, invest and raise their dividend. It is another well run story.

Financial Services
TOP PICK
Cigna Corp.

A US health insurer provider, one of the largest. There is a pending deal. Aetna (AET-N) (?) wants to buy the company, and it is unlikely that deal gets approved. If the deal doesn’t get approved, the break fee is about $1.5 billion. On top of that, when you look at the cash they can deploy, they are going to have about $10 billion to play with. They can buy back a ton of stock if the deal does not go through. If it does go through, you still get 30% upside. Dividend yield of .03%.

Financial Services
TOP PICK
Cigna Corp.

Health care insurance space, global. A company wanted to buy them and it was rejected by the US government, but they have until next April for the deal to go through. 14 times earnings. They help companies save money. Once the deal does close, or doesn’t, they will have the ability to raise the dividend.

Financial Services
BUY
Cigna Corp.

Do the benefits programs for a lot of small and medium sized businesses and individuals and will benefit from Obama care. It has traded off from fear that businesses would have to now insure all their employees.

Financial Services
Showing 1 to 14 of 14 entries
  • «
  • 1
  • »

Cigna Corp.(CI-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Cigna Corp. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Cigna Corp.(CI-N) Frequently Asked Questions

What is Cigna Corp. stock symbol?

Cigna Corp. is a American stock, trading under the symbol CI-N on the New York Stock Exchange (CI). It is usually referred to as NYSE:CI or CI-N

Is Cigna Corp. a buy or a sell?

In the last year, there was no coverage of Cigna Corp. published on Stockchase.

Is Cigna Corp. a good investment or a top pick?

Cigna Corp. was recommended as a Top Pick by on . Read the latest stock experts ratings for Cigna Corp..

Why is Cigna Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Cigna Corp. worth watching?

0 stock analysts on Stockchase covered Cigna Corp. In the last year. It is a trending stock that is worth watching.

What is Cigna Corp. stock price?

On 2024-11-21, Cigna Corp. (CI-N) stock closed at a price of $330.07.